Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers

NCT02604004 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

HIV INFECTIONS

Interventions

DRUG: Epivir ® tablet 150-mg single dose (drug reference)
DRUG: Lamivudine 150-mg tablet single dose (drug test)

Sponsor

Universidade Federal de Pernambuco